Aridis Reports Top-Line Results of the Phase 3 Double-Blinded, Superiority Trial of AR-301 For the Treatment of Staphylococcus aureus Ventilator Associated Pneumonia (VAP)
https://ir.aridispharma.com/news-releases/?qmodStoryID=5700437764688336 ...
25 January, 2023
